CIVBX
Price
$18.98
Change
-$0.07 (-0.37%)
Updated
Jun 5 closing price
Net Assets
2.4B
RERAX
Price
$56.76
Change
+$0.02 (+0.04%)
Updated
Jun 5 closing price
Net Assets
133.44B
Interact to see
Advertisement

CIVBX vs RERAX

Header iconCIVBX vs RERAX Comparison
Open Charts CIVBX vs RERAXBanner chart's image
American Funds International Vntg 529-C
Price$18.98
Change-$0.07 (-0.37%)
VolumeN/A
Net Assets2.4B
American Funds EUPAC R1
Price$56.76
Change+$0.02 (+0.04%)
VolumeN/A
Net Assets133.44B
CIVBX vs RERAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CIVBX vs. RERAX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIVBX is a StrongBuy and RERAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 133B vs. CIVBX (2.4B). RERAX pays higher dividends than CIVBX: RERAX (0.42) vs CIVBX (0.30). CIVBX was incepted earlier than RERAX: CIVBX (6 years) vs RERAX (23 years). CIVBX (1.74) is less costly to investors than RERAX (1.57). RERAX is a more actively managed with annual turnover of: 30.00 vs. CIVBX (20.00). CIVBX (250) and RERAX (250) have matching initial minimum investment requirements. CIVBX annual gain was more profitable for investors over the last year : 10.61 vs. RERAX (1.91). CIVBX return over 5 years is better than : 37.87 vs. RERAX (13.80).
CIVBXRERAXCIVBX / RERAX
Total Expense Ratio1.741.57111%
Annual Report Gross Expense Ratio1.741.57111%
Fund Existence6 years23 years-
Gain YTD18.10312.512145%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets2.4B133B2%
Annual Yield % from dividends0.300.4271%
Returns for 1 year10.611.91554%
Returns for 3 years34.4414.60236%
Returns for 5 years37.8713.80274%
Returns for 10 yearsN/A19.61-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZVSA0.650.02
+3.96%
ZyVersa Therapeutics
KRRO12.350.47
+3.96%
Korro Bio
BCYC8.510.05
+0.59%
Bicycle Therapeutics plc
MNDY305.00-0.19
-0.06%
monday.com Ltd
CWK10.18-0.09
-0.88%
Cushman & Wakefield plc